168 related articles for article (PubMed ID: 23635842)
1. Renin-angiotensin system blockers increase risk of angio-oedema.
Volpe M; Tocci G
Evid Based Med; 2013 Dec; 18(6):e52. PubMed ID: 23635842
[No Abstract] [Full Text] [Related]
2. Risks and benefits of medications in real-world practice:
Katz MH
Arch Intern Med; 2012 Nov; 172(20):1590. PubMed ID: 23070135
[No Abstract] [Full Text] [Related]
3. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
[TBL] [Abstract][Full Text] [Related]
4. Incidence of angio-oedema associated with ARBs, ACE inhibitors, and aliskiren.
BMJ; 2012 Oct; 345():e6941. PubMed ID: 23077371
[No Abstract] [Full Text] [Related]
5. [Angio-oedema and medication that interferes with the renin-angiotensin-aldosterone system--a systematic review].
Suhrs HE; Ibsen H
Ugeskr Laeger; 2012 Mar; 174(11):724-9. PubMed ID: 22409895
[TBL] [Abstract][Full Text] [Related]
6. Angioedema related to Angiotensin inhibitors.
Knecht SE; Dunn SP; Macaulay TE
J Pharm Pract; 2014 Oct; 27(5):461-5. PubMed ID: 25124378
[TBL] [Abstract][Full Text] [Related]
7. The role of angiotensin receptor blockers in patients with angiotensin-converting enzyme inhibitor-induced angioedema.
Beavers CJ; Dunn SP; Macaulay TE
Ann Pharmacother; 2011 Apr; 45(4):520-4. PubMed ID: 21427294
[TBL] [Abstract][Full Text] [Related]
8. Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.
Wadelius M; Marshall SE; Islander G; Nordang L; Karawajczyk M; Yue QY; Terreehorst I; Baranova EV; Hugosson S; Sköldefors K; Pirmohamed M; Maitland-van der Zee AH; Alfirevic A; Hallberg P; Palmer CN
Clin Pharmacol Ther; 2014 Oct; 96(4):477-81. PubMed ID: 24960520
[TBL] [Abstract][Full Text] [Related]
9. Evaluating for seasonal variation in angiotensin-converting enzyme inhibitor- and angiotensin receptor blocker-induced angioedema.
Wilson M; Frohna W; Trent G; Sauter D
Ann Allergy Asthma Immunol; 2014 Feb; 112(2):178-9. PubMed ID: 24468261
[No Abstract] [Full Text] [Related]
10. Angiotensin-converting enzyme inhibitor and visceral angio-oedema.
Chuah HS; O'Donnell D
Emerg Med Australas; 2012 Apr; 24(2):207-8. PubMed ID: 22487673
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitor-related angioedema: recognition and treatment.
Flattery MP; Sica DA
Prog Cardiovasc Nurs; 2007; 22(1):47-51. PubMed ID: 17342008
[No Abstract] [Full Text] [Related]
12. Renin angiotensin system blockers-associated angioedema in the Thai population: analysis from Thai National Pharmacovigilance Database.
Win TS; Chaiyakunapruk N; Suwankesawong W; Dilokthornsakul P; Nathisuwan S
Asian Pac J Allergy Immunol; 2015 Sep; 33(3):227-35. PubMed ID: 26342120
[TBL] [Abstract][Full Text] [Related]
13. Is dual renin-angiotensin-system blockade associated with increased risk of stroke?
Makani H; Bangalore S; Sever P; Messerli FH
JACC Heart Fail; 2013 Oct; 1(5):454-7. PubMed ID: 24621979
[No Abstract] [Full Text] [Related]
14. Treatment of Life-Threatening ACE-Inhibitor-Induced Angioedema.
Adv Emerg Nurs J; 2018; 40(4):E1. PubMed ID: 30365441
[No Abstract] [Full Text] [Related]
15. Cardiorenal disease development under chronic renin-angiotensin-aldosterone system suppression.
Sarafidis PA; Ruilope LM
J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):217-9. PubMed ID: 22389391
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative angioedema induced by angiotensin-converting enzyme inhibitors: overview and case report.
O'Ryan F; Poor DB; Hattori M
J Oral Maxillofac Surg; 2005 Apr; 63(4):551-6. PubMed ID: 15789330
[No Abstract] [Full Text] [Related]
17. Angioedema Triggered by Medication Blocking the Renin/Angiotensin System: Retrospective Study Using the French National Pharmacovigilance Database.
Faisant C; Armengol G; Bouillet L; Boccon-Gibod I; Villier C; Lévesque H; Cottin J; Massy N; Benhamou Y
J Clin Immunol; 2016 Jan; 36(1):95-102. PubMed ID: 26707788
[TBL] [Abstract][Full Text] [Related]
18. The impact of age and sex on the reporting of cough and angioedema with renin-angiotensin system inhibitors: a case/noncase study in VigiBase.
Alharbi FF; Kholod AAV; Souverein PC; Meyboom RH; de Groot MCH; de Boer A; Klungel OH
Fundam Clin Pharmacol; 2017 Dec; 31(6):676-684. PubMed ID: 28767167
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin receptor blocker-induced visceral angioedema.
Thalanayar MP; Fajt ML; Birnie KM; Ghobrial II; Petrov AA
J Investig Allergol Clin Immunol; 2015; 25(1):63-4. PubMed ID: 25898699
[No Abstract] [Full Text] [Related]
20. COVID-19 and inhibitors of the renin-angiotensin-aldosterone system.
Hussain M; Jabeen Q; Ahmad FU; Kashif-Ur-Rehman ; Fatima M; Shaukat S; Majeed A; Barkat MQ; Wu X
Expert Rev Anti Infect Ther; 2021 Jul; 19(7):815-816. PubMed ID: 33198546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
